Geodon (Ziprasidone) Is NOT Recommended When Trying to Become Pregnant
If you are actively trying to conceive, Geodon should be avoided or switched to a safer alternative antipsychotic before pregnancy, as the FDA label explicitly warns about potential fertility impairment and limited safety data. 1
Key Safety Concerns
Fertility Impairment
The FDA label clearly states that ziprasidone may impair fertility in females of reproductive potential due to increased serum prolactin levels 1. While these effects are reversible, this directly contradicts the goal of trying to conceive. Elevated prolactin can interfere with ovulation and menstrual cycles, making conception more difficult.
Limited Pregnancy Safety Data
Unlike other second-generation antipsychotics (SGAs), ziprasidone has notably scarce safety data during pregnancy 2. A 2018 systematic review examining 14,382 pregnant women exposed to SGAs found that "safety data on ziprasidone and clozapine remain scarce and insufficient for a quantitative safety evaluation" 2. This stands in stark contrast to medications like quetiapine, olanzapine, and aripiprazole, which have substantially more robust pregnancy data.
Preconception Medication Optimization
Current preconception care guidelines emphasize that "many commonly prescribed medications are considered unsafe in pregnancy and it may be necessary to switch to safer medications before conception" 3. Mental health medications specifically require individualized assessment and potential adjustment before pregnancy 3.
Clinical Algorithm for Management
If you are planning pregnancy while taking Geodon:
- Consult your prescribing psychiatrist immediately - Do not stop medications abruptly
- Consider switching to better-studied alternatives such as:
- Stabilize on the new medication for 2-3 months before attempting conception
- Enroll in the National Pregnancy Registry for Atypical Antipsychotics if you do become pregnant on ziprasidone (1-866-961-2388) 1
Important Caveats
- The single published case report of ziprasidone use throughout pregnancy resulted in a healthy baby 6, but one case cannot establish safety
- Pharmacokinetic modeling suggests dose adjustment may not be needed during pregnancy 7, but this doesn't address teratogenic risk
- Untreated psychiatric illness during pregnancy carries its own substantial risks to both mother and fetus 3
- The decision must weigh the risks of switching medications (potential relapse) against the unknown risks of ziprasidone exposure
Bottom Line
The combination of fertility impairment warnings, insufficient pregnancy safety data, and availability of better-studied alternatives makes ziprasidone a poor choice when actively trying to conceive. Work with your psychiatrist to transition to a medication with more robust pregnancy data before attempting conception, ensuring psychiatric stability is maintained throughout the process.